| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.078 | 0.08 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.086 | 0.08 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.087 | 0.08 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.04 | 0.4 |